Endovascular Abdominal Aortic Aneurysm Repair by Interventional Cardiologists (EVAR)

October 14, 2011 updated by: Abhijeet Basoor, St. Joseph Mercy Oakland Hospital
Registry for Endovascular repair of abdominal aortic aneurysm performed primarily by Interventional Cardiologists

Study Overview

Study Type

Observational

Enrollment (Actual)

170

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Pontiac, Michigan, United States, 48341
        • St. Joseph Mercy Oakland Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Study patients comprised of all patients undergoing endovascular abdominal aortic aneurysm repair performed primarily by Interventional Cardiologists in our community setting.

Description

Inclusion Criteria:

  • Patients with abdominal aortic aneurysm amenable for endovascular repair

Exclusion Criteria:

  • Pregnant patients
  • Patients less than 18 years old.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
EVAR cohort
All consecutive patients undergoing endovascular AAA repair (EVAR) in our community setting were followed for outcomes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mortality
Time Frame: mean follow up, 30 months
mean follow up, 30 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: mean follow up, 30 months
Peri-procedural (30 day) and follow up complications
mean follow up, 30 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abhijeet Basoor, MD, St. Joseph Mercy Oakland Hospital
  • Study Director: Kiritkumar Patel, MD, St. Joseph Mercy Oakland Hospital
  • Study Director: Abdul R Halabi, MD, St. Joseph Mercy Oakland Hospital
  • Study Director: Nishit Choksi, MD, St. Joseph Mercy Oakland Hospital
  • Study Director: Thanh Phan, MD, St. Joseph Mercy Oakland Hospital
  • Study Director: Michele DeGregorio, MD, St. Joseph Mercy Oakland Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

May 1, 2011

Study Completion (Actual)

May 1, 2011

Study Registration Dates

First Submitted

October 12, 2011

First Submitted That Met QC Criteria

October 14, 2011

First Posted (Estimate)

October 17, 2011

Study Record Updates

Last Update Posted (Estimate)

October 17, 2011

Last Update Submitted That Met QC Criteria

October 14, 2011

Last Verified

October 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endovascular Abdominal Aortic Aneurysm Repair (EVAR)

3
Subscribe